MedTrace Logo

Laparoscopic Cryoablation of Uterine Fibroids

NCT01735812 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-06-13

No results posted yet for this study

Summary

The goal of this study is to evaluate the safety \& efficacy of cryoablation using IceCure medical's IceSense3™ device for the treatment of symptomatic uterine fibroids in a percutaneous lap-assisted approach.

Conditions

  • Symptomatic Uterine Fibroids

Interventions

DEVICE

IceSense3 system

The IceSense3™ is a modern cryosurgical device that was designed by IceCure Medical for a variety of applications.

Sponsors & Collaborators

  • IceCure Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Moty Pansky, Prof. · Assaf Harofe Hospital, Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Israel

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01735812 on ClinicalTrials.gov